Journal of Antimicrobial Chemotherapy (1987) 20, 595-597
© 1987 The British Society for Antimicrobial Chemotherapy
research-article |
Ciprofloxacin treatment of Staphylococcus aureus infections
Toronto East General and Orthopaedic Hospital and Department of Microbiology, University of Toronto Canada
accepted 11 April 1987
Correspondence to: Dr. J. Righter, Head, Division of Microbiology, Toronto East General and Orthopaedic Hospital, 825 Coxwell Avenue, Toronto, Canada, M4C 3E7
Ciprofloxacin appears to be safe and effective for a wide variety of clinical infections. In-vitro and animal studies point to high cure rates for both methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections. Seventeen patients with staphylococcal infections severe enough to require hospital admission and initial parenteral therapy were treated with ciprofloxacin; the results were poor, with clinical failure in five and bacteriological failure in 12. All pathogens isolated were susceptible to ciprofloxacin both before and after therapy and tolerance was not detected. Further study is required before ciprofloxacin can be recommended for life threatening staphylococcal infections.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Joshi and D. Milfred The Use and Misuse of New Antibiotics: A Perspective Arch Intern Med, March 27, 1995; 155(6): 569 - 577. [Abstract] [PDF] |
||||
![]() |
M. Trucksis, D. C. Hooper, and J. S. Wolfson Emerging Resistance to Fluoroquinolones in Staphylococci: An Alert Ann Intern Med, March 1, 1991; 114(5): 424 - 426. [Abstract] [PDF] |
||||

